The litigation industry continues to evolve and grow. Consider, for example, this June 19, 2019 press release by a group of firms brining...

For those litigating drug cases, the NEJM just published an open access article with a broad set of data on medical marketing. It’s...

A cogent summary of statutes of repose for drugs and devices is online at a July 16, 2018 guest post at Drug & Device blog.

The scale of mass tort litigation is sometimes missed. The scale of “mesh MDL litigation” is nicely captured in a February 5, 2018 post...

Pasted below is a fascinating press release from a proteomics company known as SomaLogic. The gist is the scientists were able to predict...

The good news for drug companies is that a federal judge in New York agrees there is a 1st Amendment right to provide information to...

The Lance opinion from the Pennsylvania Supreme Court breaks new, negative ground for defendants in drug cases. The Drug and Device blog...

Manufacturers increasingly need to think about "cradle to grave" expenses for products. A new example arises from drugs. Some people link...

The Drug and Device blog has an interesting post today on rulings on some unusual motions in limine in a drug case. The issues include a...

Thalidomide claims are back in the popular press after a newly announced settlement in a class action case pending in Australia; the...

The post is here. Well worth reading. #Drugs #Torts

For those interested in “mass tort” issues, well worth reading is today’s National Law Journal article regarding the recent wave of...